TWi Biotechnology, Inc. (TPEX:6610)
Taiwan · Delayed Price · Currency is TWD 44.60
-1.85 (-3.98%)
Sep 30, 2026, 1:58 PM CST
TWi Biotechnology Market Cap
TWi Biotechnology has a market cap or net worth of 9.55 billion as of September 29, 2026. Its market cap has increased by 141.75% in one year.
Market Cap
9.55B
Enterprise Value
9.44B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
44.60
ChartMarket Cap Chart
Since December 27, 2016, TWi Biotechnology's market cap has increased from 3.83B to 9.55B, an increase of 149.46%. That is a compound annual growth rate of 9.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 9.46B | 423.10% |
| Dec 31, 2025 | 1.81B | 47.88% |
| Dec 31, 2024 | 1.22B | -0.52% |
| Dec 29, 2023 | 1.23B | 22.02% |
| Dec 30, 2022 | 1.01B | -7.50% |
| Dec 30, 2021 | 1.09B | 7.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AP Biosciences | 13.65B |
| Lumosa Therapeutics | 13.52B |
| Steminent Biotherapeutics | 11.00B |
| TCM Biotech International | 9.87B |
| Polaris Group | 8.09B |
| PharmaEngine | 7.96B |
| Tanvex BioPharma | 7.94B |
| Locus Cell | 7.71B |